The researchers will study brain samples from individuals with bipolar disorder, schizophrenia, and major depressive disorder.
Researchers from Hong Kong imputed transcriptomes from GWAS data and compared them to drug-induced gene expression profiles.
The study will combine cognitive assessments with genetic data and survey responses to gain insights into the causes of these two mental health conditions.
The company is collaborating with hospitals to implement sequencing and machine learning approaches to pinpoint the molecular etiology of autism earlier in age.
The presence of these variants also suggested a role for microglia in the development of late-onset Alzheimer's disease, the researchers said.
The companies will develop a smartphone-based platform to offer molecular tests enabling the precision treatment of psychiatric disorders.
Researchers found that about 17 percent of sporadic amyotrophic lateral sclerosis patients harbor at least one deleterious rare variant or repeat expansion.
A study focused on rare CNVs unearthed a subset of Tourette cases affected by deletions in the NRXN1 gene or duplications in the CNTN6 gene.
Assurex Health will use the MassArray system with its GeneSight Psychotropic pharmacogenetic test.
Researchers saw partial overlap between variants influencing age-related methylation and neuronal patterns and those implicated in other traits or diseases.
The partners have formed a public/private partnership to foster collaboration and data integration between different institutes researching brain trauma.
The researchers uncovered four Tourette disorder risk genes through exome sequencing of parent-child trios, and estimated there could be hundreds more.
Rare mutations in the ANXA11 gene showed up in cases with familial and sporadic forms of amyotrophic lateral sclerosis.
The British molecular diagnostics company plans to make its array-based test for early-stage Alzheimer's disease available in the US by year end.
The researchers noted that heritability of PTSD differed by sex, and that it overlapped with schizophrenia and other mental disorders.
PsychENCODE was established to discover non-coding functional genomic elements in the brain and elucidate their role in psychiatric disorders.
The consortium is collecting data from different omics streams for a cohort of individuals with autism spectrum disorders with the long-term goal of improving treatment.
In Williams v Quest/Athena, a federal district court judge has asked the highest state court to clarify if a genetic testing lab is a licensed healthcare provider.
Through this Alnylam-funded program, Invitae will perform free testing for US patients suspected to have hereditary ATTR amyloidosis or a family history of it.
The grant was awarded by the Human Frontier Science Program, which promotes international research collaborations.
Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.
In Sciencethis week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.
The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.
Kaiser Health News reports that gene therapies could cost more than a million dollars.